148 related articles for article (PubMed ID: 14612850)
21. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Christie DJ; Kottke-Marchant K; Gorman RT
Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
[TBL] [Abstract][Full Text] [Related]
22. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.
Dropinski J; Jakiela B; Sanak M; Wegrzyn W; Biernat M; Dziedzina S; Plutecka H; Szczeklik A
Thromb Haemost; 2007 Jul; 98(1):201-9. PubMed ID: 17598014
[TBL] [Abstract][Full Text] [Related]
23. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
Schwertner HA; McGlasson D; Christopher M; Bush AC
Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
[TBL] [Abstract][Full Text] [Related]
24. Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study.
Chairangsarit P; Sithinamsuwan P; Niyasom S; Udommongkol C; Nidhinandana S; Suwantamee J
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S148-54. PubMed ID: 16858953
[TBL] [Abstract][Full Text] [Related]
25. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF
Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496
[TBL] [Abstract][Full Text] [Related]
26. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
[TBL] [Abstract][Full Text] [Related]
27. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
Wenaweser P; Windecker S; Billinger M; Cook S; Togni M; Meier B; Haeberli A; Hess OM
Am J Cardiol; 2007 Feb; 99(3):353-6. PubMed ID: 17261397
[TBL] [Abstract][Full Text] [Related]
28. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
[TBL] [Abstract][Full Text] [Related]
29. Single oral dose study of two isosorbide-based aspirin prodrugs in the dog.
Gilmer JF; Murphy MA; Shannon JA; Breen CG; Ryder SA; Clancy JM
J Pharm Pharmacol; 2003 Oct; 55(10):1351-7. PubMed ID: 14607016
[TBL] [Abstract][Full Text] [Related]
30. Variability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population.
Mardikar H; Deo D; Deshpande N; Mardikar M; Ghosh A; Munot K; Steinhubl S; Mukherjee D
J Assoc Physicians India; 2008 May; 56():321-4. PubMed ID: 18700638
[TBL] [Abstract][Full Text] [Related]
31. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
[TBL] [Abstract][Full Text] [Related]
32. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction.
D'Andrea G; Perini F; Hasselmark L; Alecci M; Cananzi AR
Funct Neurol; 1995; 10(2):91-8. PubMed ID: 7557557
[TBL] [Abstract][Full Text] [Related]
33. Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry.
Motovska Z; Sujanova Z; Wimmerova S; Ardo J; Skrakova M; Widimsky P
Transl Res; 2007 Oct; 150(4):246-52. PubMed ID: 17900512
[TBL] [Abstract][Full Text] [Related]
34. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].
Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI
Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
Storey RF; May JA; Heptinstall S
Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.
Jakubowski JA; Payne CD; Weerakkody GJ; Brandt JT; Farid NA; Li YG; Naganuma H; Lachno DR; Winters KJ
J Cardiovasc Pharmacol; 2007 Mar; 49(3):167-73. PubMed ID: 17414229
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of antiplatelet treatment with aspirin in polymorbid patients.
Paluch Z; Jedlicková V; Skibova J; Adamek T; Alusík S
Int Angiol; 2007 Sep; 26(3):206-12. PubMed ID: 17622200
[TBL] [Abstract][Full Text] [Related]
38. Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients.
Sztriha LK; Sas K; Seres E; Boda K; Lenti L; Csifcsak G; Kovacs N; Vecsei L
Acta Neurol Scand; 2008 Apr; 117(4):250-4. PubMed ID: 17961197
[TBL] [Abstract][Full Text] [Related]
39. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
40. Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis.
Gengo FM; Rubin L; Robson M; Rainka M; Gengo MF; Mager DE; Bates V
J Clin Pharmacol; 2008 Jan; 48(1):117-22. PubMed ID: 18094224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
